CTCs were identified by positive staining for melanoma antigen recognised by T cells 1 (MART1)/glycoprotein 100(gp100)/S100 calcium-binding protein β (S100β) and negative staining for CD45 (Fig 2A). The gene discussed is PMEL; the disease is melanoma.